TAIHO PHARMACEUTICAL CO LTD vs THE CONTROLLER OF PATENTS

Judgment text excerpt

* IN THE HIGH COURT OF DELHI AT NEW DELHI % Judgment Reserved on: 23.04.2025 Judgment pronounced on: 15.05.2025 + C.A. (COMM.IPD-PAT) 6/2022 TAIHO PHARMACEUTICAL CO. LTD. .....Appellant Through: Mr. Ankush Verma, Mr. Debashish Banerjee, Ms. Vaishali Joshi, Mr.Vineet Rohilla, Mr. Pankaj Soni, Mr.Rohit Rangi, Mr. Tanveer Malhotra & Ms. Gurmeet Kaur, Advocates. versus THE CONTROLLER OF PATENTS .....Respondent Through: Mr. Premtosh K. Mishra, CGSC with Mr. Manish Vashisht, Ms. Sanya Kalsi and Mr. Prakhar Singh, Advocates. CORAM: HON’BLE MR. JUSTICE AMIT BANSAL JUDGMENT AMIT BANSAL, J. 1. The present appeal has been filed under Section 117A of the Patents Act, 1970 (hereinafter ‘Act’) and is directed against the order dated 18th June, 2021 (hereinafter ‘impugned order’) passed by the Assistant Controller of Patents and Designs (hereinafter ‘Controller’), whereby the Indian Patent Application No. 7283/DELNP/2014 titled ‘Novel Piperidine Compound or Salt thereof’ (hereinafter ‘subject patent application’) has been refused. Signature Not Verified Digitally Signed C.A. (COMM.IPD-PAT) 6/2022 Page 1 of 15 By:VIVEK MISHRA Signing Date:15.05.2025 15:23:54 BRIEF FACTS 2. Brief facts necessary for deciding the present appeal are set out below: 2.1. The appellant, Taiho Pharmaceutical Co. Ltd., is an entity based in Japan. 2.2. The subject patent application was filed as a national-phase application under the Patent Cooperation Treaty (‘PCT’), claiming priority from a Japanese Patent Application with a priority date of 27 th August, 2012. The appellant had filed the subject patent application on 29 th August, 2014, with the Indian Patent Office, Delhi. The bibliographic details of the application are given below: Indian Application No. 7283/DELNP/20 14 Applicant TAIHO PHARMACEUTICAL CO